SCHEMBL8561209

SCHEMBL8561209

CCOC(=O)C1=C(C)OC(C)=C(C(=O)OC)C1c1ccc(Cl)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 1/20 0.63
HPGD P15428 4/20 0.61
NPSR1 Q6W5P4 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
KDM4E B2RXH2 4/20 0.57
CACNA1F O60840 1/20 0.56
CACNA1D Q01668 1/20 0.56
CACNA1S Q13698 1/20 0.56
CACNA1C Q13936 1/20 0.56
ADORA3 P0DMS8 2/20 0.53
ACHE P22303 1/20 0.53
HTT P42858 1/20 0.52
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 4/20 0.48
GAA P10253 2/20 0.48
HSD17B10 Q99714 2/20 0.48
LMNA P02545 1/20 0.48
GLA P06280 1/20 0.48
POLB P06746 1/20 0.48
CASP1 P29466 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8562068 0.92 HPGD (0.66) ABCC1HPGDNPSR1SMN1; SMN2KDM4E
SCHEMBL8024613 0.80 ALDH1A1 (0.67) HPGDSMN1; SMN2KDM4EADORA3ACHE
SCHEMBL3030945 0.77 ABCC1 (1.00) ABCC1HPGDNPSR1SMN1; SMN2KDM4E
SCHEMBL7920096 0.76 ALDH1A1 (0.66) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL8562368 0.75 HPGD (0.46) ABCC1HPGDNPSR1SMN1; SMN2KDM4E
SCHEMBL8040446 0.75 KDM4E (0.46) ABCC1HPGDNPSR1SMN1; SMN2KDM4E
SCHEMBL8381158 0.74 ALDH1A1 (0.78) HPGDSMN1; SMN2KDM4EHTTKMT2A
SCHEMBL10895180 0.74 CACNA1F (0.76) ABCC1HPGDNPSR1SMN1; SMN2KDM4E
SCHEMBL8558368 0.74 KDM4E (0.47) ABCC1HPGDNPSR1SMN1; SMN2KDM4E
SCHEMBL10886798 0.73 ADORA3 (0.72) ABCC1HPGDNPSR1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760073-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1998-06-02 US disclosed